HIV jab for 115 nations rests on Indian regulators | India News
Mumbai: There will be a dramatic shift in how the world prevents HIV and the timelines depend on how quickly Indian drug regulators act. A US-based pharma giant has granted royalty-free licences to four Indian generic manufacturers to produce lenacapavir, which prevents transmission by almost 100%, at $40 per person per year, roughly 0.1% of…

